Tonix Pharmaceuticals
TNXP
trading on NASDAQ
since 2009
Tonix Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for central nervous system disorders and pain management through its pipeline of small-molecule medications.
type | open | high | low |
market cap |
volume |
---|---|---|---|---|---|
stock | $45.65 | $61.20 | $42.12 | $342.04M | 3.52M |
eps | p/e | p/s |
operating margin |
profit margin |
yield |
-$2.84 | n/a | 146.41 | -660.93% | -692.84% | 0% |